Dynamic flow promotes airway MPS maturation and host response to viral infection
Background High attrition rates in infectious disease drug and vaccine development are partly attributed to preclinical models that inadequately recapitulate the human airway microenvironment. Although dynamic flow microphysiological systems (MPS) have been proposed as more physiologically relevant alternatives to static culture, direct benchmarking in respiratory infection models remains limited. Methods We directly compared primary human airway MPS established under static conditions or continuous basolateral perfusion. Tissue organisation, epithelial differentiation, barrier integrity, spatial infection phenotypes, and host transcriptional responses were assessed following infection with SARS-CoV-2 variants (Pre-alpha, Delta, and Omicron BA.5). Results Dynamic flow promoted improved epithelial organisation without major alterations in baseline gene expression, consistent with accelerated differentiation kinetics rather than shifts in cell composition. Both static and dynamic systems supported productive SARS-CoV-2 infection; however, dynamic flow cultures demonstrated reduced inter-replicate variability and improved robustness of quantitative readouts. Spatial imaging revealed reproducible higher-order phenotypes, including variant-dependent syncytia formation. Transcriptomic analyses showed increased effect sizes and reduced variance under dynamic flow, resulting in improved discrimination between infected and mock tissues and greater confidence in pathway-level interpretation. Interferon-driven host responses aligned with published patient-derived datasets, supporting biological relevance. Conclusions While static airway models are sufficient for basic infection kinetics, incorporation of dynamic flow enhances reproducibility, sensitivity, and mechanistic interpretability between replicates. Dynamic flow airway MPS therefore provide a more reliable platform for comparative studies and may provide sufficient resolution to support intervention assessment, providing improved translational confidence in preclinical respiratory infection research. As continuous perfusion is required for integration into interconnected multi-organ pharmacokinetic systems, these findings also support the use of dynamic flow airway MPS within multi-organ chips.
Authors
- Giancarlo A. Biagini (ORCID: https://orcid.org/0000-0001-6356-6595)
- Eric R. Lucas (ORCID: https://orcid.org/0000-0003-3892-1668)
- Nick Heavey
- Rose C. Lopeman
- Shaun H. Pennington (ORCID: https://orcid.org/0000-0002-7160-6275)
- Chris Williams (ORCID: https://orcid.org/0000-0003-1757-6156)
- Thomas Edwards (ORCID: https://orcid.org/0000-0003-4058-4461)
- Dominic Wooding (ORCID: https://orcid.org/0000-0002-9985-0413)
- Andrew Owen (ORCID: https://orcid.org/0000-0002-9819-7651)
- Tomasz M. Kostrzewski (ORCID: https://orcid.org/0000-0001-6309-628X)
- Claire H Caygill (ORCID: https://orcid.org/0000-0002-5546-9346)
- Aitor Casas-Sánchez (ORCID: https://orcid.org/0000-0001-5237-1223)
- Louise Howard
- Emily Richardson
Institutions
- University of Liverpool (GB)
- Liverpool School of Tropical Medicine (GB)
- University of Cambridge (GB)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2026-11-19
- DOI
- https://doi.org/10.3389/fimmu.2026.1993146
- Citations
- 1
- Primary Topic
- SARS-CoV-2 and COVID-19 Research
- Type
- article
- Field-Weighted Citation Impact
- 3.02
Funders
- UK Research and Innovation